Hydrolysis of the prodrug, 2',3',5'-triacetyl-6-azauridine. 1995

C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
Department of Pharmaceutical Chemistry, University of Kansas, Lawrence 66045-2504, USA.

OBJECTIVE The purposes were to study the kinetics of hydrolysis of 2',3',5'-triacetyl-6-azauridine (1) in aqueous solution (mu = 0.5) and to identify the main intermediates and products of the reaction. METHODS A stability indicating isocratic LC assay was used to study the rate of degradation of 1. A gradient LC assay was used to study the time courses of the degradants. The products of hydrolysis were isolated by preparative liquid chromatography and identified by 1H-NMR and CI-MS. The pKa value was obtained by potentiometric titration. RESULTS At 36.8 degrees C, the pH-rate profile of 1 in water was adequately described by a four-term rate equation. The intermediates were identified as the primary and secondary di-acetates, and the primary and secondary mono-acetates. The final product was 6-azauridine. CONCLUSIONS A simplified kinetic scheme could be used to describe the concentration-time profiles of 1, the intermediates and the final product.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D001380 Azauridine A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic. 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione,6-Azauridine,6 Azauridine
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D013816 Thermodynamics A rigorously mathematical analysis of energy relationships (heat, work, temperature, and equilibrium). It describes systems whose states are determined by thermal parameters, such as temperature, in addition to mechanical and electromagnetic parameters. (From Hawley's Condensed Chemical Dictionary, 12th ed) Thermodynamic

Related Publications

C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
March 1963, Cancer research,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
December 2001, Journal of pharmaceutical and biomedical analysis,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
February 1962, Cancer chemotherapy reports,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
September 1970, American journal of obstetrics and gynecology,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
December 1964, The Journal of investigative dermatology,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
December 1977, Archives for dermatological research = Archiv fur dermatologische Forschung,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
October 1969, The Indian journal of medical research,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
January 1966, Neoplasma,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
March 1970, The Indian journal of medical research,
C M Riley, and M A Mummert, and J Zhou, and R L Schowen, and D G Vander Velde, and M D Morton, and M Slavik
August 1971, Biochemical pharmacology,
Copied contents to your clipboard!